236 related articles for article (PubMed ID: 25701988)
1. Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.
Obaro SK
Lancet Glob Health; 2015 Mar; 3(3):e124-5. PubMed ID: 25701988
[No Abstract] [Full Text] [Related]
2. Hydroxycarbamide for sickle-cell anaemia in infancy.
Weatherall DJ
Lancet; 2011 May; 377(9778):1628-30. PubMed ID: 21571132
[No Abstract] [Full Text] [Related]
3. Hydroxurea and sickle cell disease: Its been a long, long time coming.
Scott JP
Pediatr Blood Cancer; 2010 Feb; 54(2):185-6. PubMed ID: 19908298
[No Abstract] [Full Text] [Related]
4. Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi.
Mvalo T; Topazian H; Kamthunzi P; Chen J; Kambalame I; Mafunga P; Mumba N; Chiume-Chiphaliwali M; Paseli K; Key N; Gopal S; Hoffman I; Ataga K; Westmoreland K
Blood Adv; 2018 Nov; 2(Suppl 1):30-32. PubMed ID: 30504195
[No Abstract] [Full Text] [Related]
5. Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.
Tripathi A; Jerrell JM; Stallworth JR
Pediatr Blood Cancer; 2011 Jan; 56(1):90-4. PubMed ID: 20922765
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease.
Gille AS; Pondarré C; Dalle JH; Bernaudin F; Chalas C; Fahd M; Jean C; Lezeau H; Riou L; Drouineaud V; Paye-Jaouen A; Kamdem A; Neven B; Arnaud C; Azarnoush S; Yakouben K; Sarnacki S; de Montalembert M; Comperat EM; Lenaour G; Sibony M; Dhédin N; Vaiman D; Wolf JP; Patrat C; Fouchet P; Poirot C; Barraud-Lange V
Blood; 2021 Feb; 137(6):856-859. PubMed ID: 33259585
[No Abstract] [Full Text] [Related]
7. Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia.
Taylor JG; Darbari DS; Maric I; McIver Z; Arthur DC
Ann Intern Med; 2011 Nov; 155(10):722-4. PubMed ID: 22084346
[No Abstract] [Full Text] [Related]
8. Treating sickle cell anaemia with hydroxycarbamide.
Pollack S
Br J Haematol; 2014 Jan; 164(2):296-7. PubMed ID: 24116862
[No Abstract] [Full Text] [Related]
9. Hydroxyurea for ALL children with sickle cell anemia: What can we learn from Africa?
Aygun B
Pediatr Blood Cancer; 2020 Apr; 67(4):e28164. PubMed ID: 31925887
[No Abstract] [Full Text] [Related]
10. Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review.
DeBaun MR
Expert Rev Hematol; 2014 Dec; 7(6):767-73. PubMed ID: 25242414
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria.
Ofakunrin AOD; Oguche S; Adekola K; Okpe ES; Afolaranmi TO; Diaku-Akinwumi IN; Zoakah AI; Sagay AS
J Trop Pediatr; 2020 Jun; 66(3):290-298. PubMed ID: 31608959
[TBL] [Abstract][Full Text] [Related]
12. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].
Nkashama GM; Wakamb GK; Mulangu AM; Nkashama GM; Kupa BK; Numbi OL
Pan Afr Med J; 2015; 21():124. PubMed ID: 26327961
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.
Zahr RS; Hankins JS; Kang G; Li C; Wang WC; Lebensburger J; Estepp JH
Am J Hematol; 2019 Jan; 94(1):E27-E29. PubMed ID: 30359463
[No Abstract] [Full Text] [Related]
14. Hydroxyurea therapy for sickle cell anemia.
McGann PT; Ware RE
Expert Opin Drug Saf; 2015; 14(11):1749-58. PubMed ID: 26366626
[TBL] [Abstract][Full Text] [Related]
15. Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease.
Brandow AM; Panepinto JA
Am J Hematol; 2011 Sep; 86(9):804-6. PubMed ID: 21815183
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea use among children with sickle cell anemia.
Reeves SL; Jary HK; Gondhi JP; Raphael JL; Lisabeth LD; Dombkowski KJ
Pediatr Blood Cancer; 2019 Jun; 66(6):e27721. PubMed ID: 30900800
[TBL] [Abstract][Full Text] [Related]
17. Long-term data from the REACH study testing hydroxyurea to treat sickle cell anaemia in children in sub-Saharan Africa.
Galadanci NA; Kanter J
Lancet Haematol; 2024 Jun; 11(6):e393-e395. PubMed ID: 38701813
[No Abstract] [Full Text] [Related]
18. Treatment adherence in patients with sickle cell anemia.
Drotar D
J Pediatr; 2010 Mar; 156(3):350-1. PubMed ID: 20056235
[No Abstract] [Full Text] [Related]
19. Two assays to evaluate potential genotoxic effects of hydroxyurea in sickle cell disease patients.
Rodríguez A; Kouegnigan L; Ferster A; Cotton F; Duez P
Hemoglobin; 2012; 36(6):545-54. PubMed ID: 23094637
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.
Aygun B; Lane A; Smart LR; Santos B; Tshilolo L; Williams TN; Olupot-Olupot P; Stuber SE; Tomlinson G; Latham T; Ware RE;
Lancet Haematol; 2024 Jun; 11(6):e425-e435. PubMed ID: 38701812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
